Initial reaction is it looks like a good one. And guiding for another 10-15% next year. Need to digest the details, but the business looks too be going well.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025